3 results
Approved WMOCompleted
The aim of this study is to determine whether LNP023 is effective and safe for the treatment of PNH. LNP023 is compared to the Standard of Care (SOC) anti-C5 antibody treatment. The primary objectives are to:• Demonstrate superiority of LNP023…
Approved WMOCompleted
The objective of the study is to characterize the performance of biologically assisted core decompression performed with the PerFuse instrument and BioCUE for the treatment AVN of the femoral head. The study will explore the potential impact of…
Approved WMOCompleted
The primary objective of this study is to assess the pharmacokinetics (PK), pharmacodynamics (PD), safety, andefficacy of ALXN1210 in pediatric patients with paroxysmal nocturnal hemoglobinuria (PNH).